Oncology Corporate Profile
Pique Therapeutics is a biopharmaceutical company seeking to become the leader in the development and commercialization of new therapeutic vaccines, focused initially on the treatment of cancer. The Company was founded on the research of Eckhard R. Podack, M.D., Ph.D., who is Chair of the Department of Immunology and Microbiology at the University of Miami.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|PT 107||allogeneic B7.1/HLA-A1 transfected tumor cell vaccine||Non Small Cell Lung Cancer (NSCLC)||II|
|PT 128||allogeneic B7.1/HLA-A1 transfected tumor cell vaccine||Colorectal cancer||Preclinical|
|PT 207||allogeneic B7.1/HLA-A1 transfected tumor cell vaccine||Head & Neck cancer||Preclinical|
|PT 123||allogeneic B7.1/HLA-A1 transfected tumor cell vaccine||Pancreatic cancer||Preclinical|
View additional information on product candidates here »